HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Playtex board grows

This article was originally published in The Rose Sheet

Executive Summary

Playtex Products elects Maureen Tart-Bezer to its board of directors, firm announces May 2. "An experienced financial and management executive," Tart-Bezer has served as the executive VP and CFO of Virgin Mobile USA, executive VP and general manager of the American Express Company's consumer group, and as a senior financial officer at AT&T, Playtex says. She currently serves as director to The Great Atlantic & Pacific Tea Company. Tart-Bezer is "a welcome addition to our Board of Directors. We expect that her strong financial background and significant management experience will benefit Playtex as we evolve from being a turnaround situation to being a growth-oriented company," CEO Neil DeFeo states. In April, Playtex acquired Hawaiian Tropic sun care (1"The Rose Sheet" April 23, 2007, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014700

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel